RESUMEN
INTRODUCCIÓN. El cáncer de mama resulta una de las neoplasias malignas más frecuente en las mujeres y se asocia con una alta morbilidad y mortalidad a nivel mundial. OBJETIVO. Caracterizar el manejo quirúrgico del cáncer de mama. MATERIALES Y MÉTODOS. Se desarrolló un estudio con enfoque mixto, descriptivo transversal, con una muestra de 80 pacientes. Criterios de inclusión; intervenidas quirúrgicamente mediante mastectomía lateral debido a un diagnóstico de cáncer de mamas. En la Unidad Oncológica de la Sociedad Oncológica de Lucha Contra el Cáncer, Chimborazo, durante el período 2015-2017. Se realizó la revisión de Historias Clínicas Únicas que permitió recopilar los datos mediante la respectiva ficha. Se analizó los datos en el programa Microsoft Excel. RESULTADOS. El 63,75 % (51;80) fue de etnia mestiza y aquellas con edades superiores a 50 años 56,23% (45;80). No existió diferencias importantes entre las prácticas conservadoras con respecto a radicales. La mayoría de los diagnósticos se realizaron en el estadío III, de lateralidad izquierda 63,75% (51;80) y con receptores hormonales luminal A. CONCLUSIÓN. El tratamiento adyuvante resultó el que más se aplicó a las afectadas, no reportándose casos de recurrencia o de progresión de la enfermedad.
INTRODUCTION. Breast cancer is one of the most common malignancies in women and is associated with high morbidity and mortality worldwide. OBJECTIVE. Characterize the surgical management of breast cancer. MATERIALS AND METHODS. A study with a mixed, descriptive, cross-sectional approach was developed with a sample of 80 patients. Inclusion criteria; underwent surgery by lateral mastectomy due to a diagnosis of breast cancer. In the Oncology Unit of the Oncology Society for the Fight Against Cancer, Chimborazo, during the period 2015-2017. The review of Unique Clinical Histories was carried out, which allowed data to be collected through the respective file. The data was analyzed in the Microsoft Excel program. RESULTS 63,75% (51; 80) were of mixed race ethnicity and those with ages over 50 years old 56,23% (45; 80). There were no significant differences between conservative practices with respect to radicals. The majority of diagnoses were made in stage III, with 63,75% left laterality (51; 80) and with luminal hormone receptors A. CONCLUSION. The adjuvant treatment was the one that was most applied to those affected, with no reports of recurrence or disease progression.
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Mujeres , Neoplasias de la Mama , Prevención de Enfermedades , Tratamiento Conservador , Cuidados para Prolongación de la Vida , Mastectomía , Morbilidad , Mortalidad , Metástasis de la NeoplasiaRESUMEN
The health service of chemical defense medicine is an important guarantee for national security, which has been expanded from dealing with traditional pure chemical warfare to current medical treatment of poisoning caused by public chemical accident, chemical terrorist attack, or future potential toxic agents at the boundary of chemistry and biology. The most recent scientific and technical disciplines, such as synthetic biology, pharmaceutical bioinformatics, nanotechnology, or drug/device combinatorial technology, should be utilized greatly to enhance the ability of the health service of the chemical defense medicine. And it is also important to establish and improve such management practice of emergence medicine as shelf life extension program or emergency use authorization.
RESUMEN
The health service of chemical defense medicine is an important guarantee for national security, which has been expanded from dealing with traditional pure chemical warfare to current medical treatment of poisoning caused by public chemical accident, chemical terrorist attack, or future potential toxic agents at the boundary of chemistry and biology. The most recent scientific and technical disciplines, such as synthetic biology, pharmaceutical bioinformatics, nanotechnology, or drug/device combinatorial technology, should be utilized greatly to enhance the ability of the health service of the chemical defense medicine. And it is also important to establish and improve such management practice of emergence medicine as shelf life extension program or emergency use authorization.
RESUMEN
Objective Modified Decoction for Driving Out Blood Stasis in the Blood Mannsion on ascites tumor model of transplanted H22 anti-tumor effect and the impact of VEGF. Methods Adult male mice 100, inoculated with H22 hepatoma cells, the establishment of ascites H22 transplanted tumor model, then divided into 10 groups were given saline, capecitabine, flavored Modified Decoction for Driving Out Blood Stasis in the Blood Mannsion (high, medium and low dose) was administered orally for 10 days, 11 days of treatment, observation of suppression tumor rate, the rate of change in life extension; detected by immunohistochemistry the expression of VEGF in tumors, SPSS13.0 software for statistical analysis. Results Capecitabine, flavored Xuefuzhuyutang (high, medium and low dose) inhibited tumor growth rates were 60%, 49%, 41%, 35%, life extension rate of the three groups were 1.68% 157.98%, 70.58%, 49.57% higher. Conclusion Modified Decoction for Driving Out Blood Stasis in the Blood Mannsion can inhibit tumor cell proliferation in tumor-bearing mice, significantly prolonged the survival time of mice, reduce the tumor tissue and tumor tissue expression of VEGF.
RESUMEN
X-Ray tube is the core part of CT machines and its service life is closely tied to its quality,installation & adjustments and the status of the equipment itself.Besides,whether the operaters use the equipment correctly or not also influence the life of X-ray tubes.The author summarizes some methods for extending the life of CT tubes according to the experiences of installation,adjustment and using of the CT tubes for many years.